The “cost” of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice
Open Access
- 8 March 2013
- journal article
- research article
- Published by Springer Nature in BMC Family Practice
- Vol. 14 (1) , 32
Abstract
To describe the current treatment gap in management of cardiovascular risk factors in patients with poorly controlled type 2 diabetes in general practice as well as the associated financial and therapeutic burden of pharmacological treatment.Keywords
This publication has 25 references indexed in Scilit:
- A comparison of chronic illness care quality in US and UK family medicine practices prior to pay-for-performance initiativesFamily Practice, 2009
- Drug Treatment and Cost of Cardiovascular Disease in AustraliaCardiovascular Therapeutics, 2009
- National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007Archives of internal medicine (1960), 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Tackling therapeutic inertia: role of treatment data in quality indicatorsBMJ, 2007
- Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated HemoglobinThe Annals of Family Medicine, 2007
- Patient Engagement and Coaching for Health: The PEACH study – a cluster randomised controlled trial using the telephone to coach people with type 2 diabetes to engage with their GPs to improve diabetes care: a study protocolBMC Family Practice, 2007
- Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practiceQuality and Safety in Health Care, 2006
- The obesity‐driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes StudyInternal Medicine Journal, 2006
- Management of diabetes: are doctors framing the benefits from the wrong perspective?BMJ, 2001